Navigation Links
Dr. Robert J. Rubin to Join Halt Board as Reimbursement Advisor
Date:7/26/2010

LIVERMORE, Calif., July 26 /PRNewswire/ -- Halt Medical, Inc. announced today that Robert J. Rubin, M.D. has been appointed to its Scientific Advisory Board.  Dr. Rubin will also be a consultant to the company, helping to develop and implement comprehensive reimbursement strategies.  Dr. Rubin's distinguished career has included significant contributions in the fields of medicine, government, and business. Currently, he is Clinical Professor of Medicine at Georgetown University's School of Medicine and serves as a consultant to several international healthcare companies. Among his positions in government, Dr. Rubin served as Assistant Secretary, U.S. Department of Health and Human Services (DHHS), concurrent with his appointment as Assistant Surgeon General from 1981 to 1984.  Among his positions in business, Dr. Rubin served as president of the leading healthcare consulting firm, The Lewin Group, Inc., and its predecessor organizations, from 1987 to 2001.

"Dr. Rubin brings to Halt Medical significant medical and business expertise", commented Jeff Cohen, Halt's Chief Executive Officer.  "While Dr. Rubin was at the DHHS, he was responsible for passage of Medicare's Prospective Payment System.  His guidance will add significant value to Halt, particularly in the areas of public and private sector reimbursement strategies for the Halt Fibroid Procedure".  

About Halt Medical, Inc.

Halt Medical, Inc. is a late-stage medical device design and manufacturing company developing products to ablate tissue with its next generation Radiofrequency Volumetric Thermal Ablation (RFVTA) system.  The Halt system has been cleared by the FDA for general use and is currently being studied in the US for relief of symptoms caused by uterine fibroids.  Halt is preparing to commercialize the Halt Fibroid System in Europe where it has recently obtained the CE mark for general and fibroid indications.  The worldwide business opportunity for the Halt Fibroid System is estimated to be over $2 billion annually.  

Information about the Halt Fibroid Study and a list of clinical sites in the U.S. may be found at

www.clinicaltrials.gov, study number NCT00874029.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
4. Veridiam Names Robert Mazzacavallo New CFO
5. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
6. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
7. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
8. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
9. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
10. PolyTouch Medical Ltd. Announces the Appointment of Robert D. Fanelli, MD, FACS, FASGE as Medical Advisor
11. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... 2016 According to a new market ... - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast ... U.S. was valued at US$ 5.89 Bn in 2014 and ... 2015 to 2023 to reach US$ 7.99 Bn in 2023. ... emerging needle free drug delivery devices and the market is ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... to students studying complementary medicine. Allison Outerbridge is this year’s Life University ... on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
Breaking Medicine News(10 mins):